Analogic Corporation (NASDAQ:ALOG) Files An 8-K Regulation FD Disclosure

Item7.01

Attached as Exhibit 99.1, and furnished for purposes of
Regulation FD, is an investor presentation to be given by
Analogic Corporation at investor meetings to be held on March15,
2017.

The information in this Current Report on Form 8-K (including
Exhibit99.1) is being furnished to Item7.01 and shall not be
deemed to be filed for purposes of Section18 of the Securities
Exchange Act of 1934 (the Exchange Act) or otherwise subject to
the liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act
of 1933 or the Exchange Act. The information set forth in this
Item7.01 shall not be deemed an admission as to the materiality
of any information in this Current Report on Form 8-K that is
required to be disclosed solely to satisfy the requirements of
Regulation FD.

About Analogic Corporation (NASDAQ:ALOG)

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. The Company’s Ultrasound business segment provides ultrasound procedure guidance systems for the urology and surgery markets. The Company’s Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.

Analogic Corporation (NASDAQ:ALOG) Recent Trading Information

Analogic Corporation (NASDAQ:ALOG) closed its last trading session up +0.85 at 74.45 with 110,299 shares trading hands.